|
⚲
|
| Keyboard |
| Hanlon Suzanne M
✚
|
|
|---|---|
| CIK # | 0001631682 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001631682] | |
| 4 | [0001631682] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Zynerba Pharmaceuticals Inc | |
| Hanlon Suzanne M |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zynerba Pharmaceuticals Inc ZYNE
Stock Option (right to buy) · derivative
|
2021-01-21 | Grant | 55,000 | $0.00 | |
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2021-01-21 | Grant | 37,000 | $0.00 | |
|
Zynerba Pharmaceuticals Inc ZYNE
Stock Option (right to buy) · derivative
|
2020-01-30 | Grant | 60,000 | $0.00 | |
|
Zynerba Pharmaceuticals Inc ZYNE
Stock Option (right to buy) · derivative
|
2019-01-24 | Grant | 52,859 | $0.00 | |
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2018-08-06 | Buy | 3,800 | $5.80 | 22,040 |
|
Zynerba Pharmaceuticals Inc ZYNE
Stock Option (right to buy) · derivative
|
2018-01-11 | Grant | 42,700 | $0.00 | |
|
Zynerba Pharmaceuticals Inc ZYNE
Stock Option (right to buy) · derivative
|
2017-01-25 | Grant | 60,000 | $0.00 | |
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2016-08-16 | Sell | 3,000 | $10.53 | 31,590 |
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2015-08-05 | Buy | 3,000 | $17.92 | 53,760 |
|
Zynerba Pharmaceuticals Inc ZYNE
Stock Option · derivative
|
2015-08-04 | Grant | 46,616 | $0.00 |